Gail Holland

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 3

Top Topics

Placebo Controlled

Top Venues

Nature medicine

Pilot and feasibility studies

This page only lists publications with an associated author ORCID identifier.

Publications

Danijela Tatovic, Ashish Marwaha, Peter Taylor, Stephanie J Hanna, Kym Carter, Wai Yee Cheung, Steve Luzio, Gareth Dunseath, Hayley Anne Hutchings, Gail Holland, Steve Hiles, Gregory W Fegan, Evangelia Williams, Jennie Hsiu Mien Yang, Clara Domingo-Vila, Emily Pollock, Muntaha Wadud, Kirsten Ward-Hartstonge, Susie Marques-Jones, Jane Bowen-Morris, Rachel Stenson, Megan K Levings, John W Gregory, Timothy I M Tree, Colin Dayan, null null
Ustekinumab for type 1 diabetes in adolescents: a multicenter, double-blind, randomized phase 2 trial. Nature medicine (2024)
Hayley Anne Hutchings, Kirsty J Lanyon, Steven Lister, Raza Alikhan, Julian P J Halcox, Gail Holland, Arfon Hughes, Rhys Jenkins, Hamish Laing, Trudie Ca Lobban, Diane Owen, Kevin G Pollock, Ceri Todd, Kathie Wareham
Investigating the feasibility of recruitment to an observational, quality-of-life study of patients diagnosed with atrial fibrillation (AF) who have experienced a bleed while anticoagulated: EQUAL-AF feasibility study protocol. Pilot and feasibility studies 8 (1) (2022)
John W Gregory, Kymberley Carter, Wai Yee Cheung, Gail Holland, Jane Bowen-Morris, Stephen D Luzio, Gareth J Dunseath, Timothy I M Tree, Jennie Hsiu Mien Yang, Ashish Marwaha, Mohammad Alhadj Ali, Nadim Bashir, Hayley Anne Hutchings, Gregory W Fegan, Rachel Stenson, Stephen Hiles, Susie Marques-Jones, Amy Brown, Danijela Tatovic, Colin M Dayan
Phase II multicentre, double-blind, randomised trial of ustekinumab in adolescents with new-onset type 1 diabetes (USTEK1D): trial protocol. BMJ open 11 (10) (2021)